Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 16, 2012

View Archived Issues

New resource makes genome data and interpretations public

Chinese researchers present novel inhibitors of platelet aggregation

Nerviano Medical Sciences discloses new protein kinase inhibitors

Novartis patents new CDK9/cyclin-T1 inhibitors

Novel B-raf inhibitors divulged by Boehringer Ingelheim

Novel RAR-related orphan receptor-gamma modulators developed

Novel candidate HIV drugs designed by GlaxoSmithKline

Curegenix reports new lysophospholipid LPA1 receptor antagonists

New candidate analgesics synthesized at Eli Lilly

Model allows prediction of bacterial responses to multidrug combinations

New potential stroke therapeutic enters clinic

Ark Therapeutics and EMD Millipore take first collaborative steps for virus vaccines

ReNeuron clear to advance phase I stem cell trial

European study reveals new marker of stroke outcome

Treatment begins in phase I trial of SOR-C13

Biovest holds end-of-phase III meeting for BiovaxID

FDA advisory committee schedules review of lomitapide NDA

Aptalis launches new pancrelipase tablets in U.S.

Fusion protein blocking BMP signaling stimulates bone formation

HSV-2 vaccine enters phase I/IIa study

Sublingual fibromyalgia medication shows promise for chronic use

GMP development of CS-TATI-1 begins

Mologen announces progress in first half of 2012

FDA accepts complete response regarding Ampligen NDA

Natural immunomodulator for Crohn's disease enters new trial

Debio-0932 enters new NSCLC study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...